Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy

J Physiol. 2009 Oct 1;587(Pt 19):4725-36. doi: 10.1113/jphysiol.2009.176461. Epub 2009 Aug 12.

Abstract

Regular physical activity is beneficial in preventing the risk of cardiovascular complications of diabetes. Recent studies showed a cardioprotective role of oxytocin (OT) to induce natriuretic peptides (NPs) and nitric oxide (NO) release. It is not known if the diabetic state is associated with a reduced OT-NPs-NO system and if exercise training improves this system. To address this, we investigated the effects of treadmill running using the db/db mouse model of type 2 diabetes. Eight-week-old db/db mice were subjected to running 5 days per week for a period of 8 weeks. The lean db/+ littermates were used as controls. Sedentary db/db mice were obese and hyperglycaemic, and exercise training was not effective in reducing body weight and the hyperglycaemic state. Compared to control mice, db/db mice had lower heart weight and heart-to-body weight ratios. In these mice, this was associated with augmented cardiac apoptosis, cardiomyocyte enlargement and collagen deposits. In addition, db/db mice displayed significant downregulation in gene expression of OT (76%), OT receptors (65%), atrial NP (ANP; 43%), brain NP (BNP; 87%) and endothelial nitric oxide synthase (eNOS) (54%) in the heart (P < 0.05). Exercise training had no effect on expression of these genes which were stimulated in control mice. In response to exercise training, the significant increment of anti-apoptotic Bcl-2 gene expression was observed only in control mice (P < 0.05). In conclusion, downregulation of the OT-NPs-NO system occurs in the heart of the young db/db mouse. Exercise training was not effective in reversing the defect, suggesting impairment of this cardiac protective system in diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Cardiomyopathies / etiology*
  • Cardiomyopathies / genetics
  • Cardiomyopathies / pathology
  • Cardiomyopathies / prevention & control
  • DNA Primers / genetics
  • Diabetes Complications / etiology
  • Diabetes Complications / genetics
  • Diabetes Complications / pathology
  • Diabetes Complications / prevention & control
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetes Mellitus, Type 2 / therapy
  • Disease Models, Animal
  • Down-Regulation
  • Genes, bcl-2
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Natriuretic Peptides / genetics*
  • Nitric Oxide Synthase Type III / genetics
  • Oxytocin / genetics*
  • Physical Conditioning, Animal
  • Physical Exertion
  • Receptors, Oxytocin / genetics
  • Risk Factors

Substances

  • DNA Primers
  • Natriuretic Peptides
  • Receptors, Oxytocin
  • Oxytocin
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse